Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?

Retrospective study of 133 patients who underwent multiparametric MRI before radical prostatectomy.  The MRI results were compared to clinical scoring systems, with pathology (tumour<0.5cc) as the reference standard for assessing eligibility for Active Surveillance. 14/133 would have been eligible for AS based on pathologic results, and the MRI was highly accurate for predicting eligibility for AS.

D'Amico system:  sensitivity 93%, PPV 25%, and accuracy 70%.

Epstein criteria: sensitivity 64%, PPV 45%, and accuracy 88%. 

CAPRA system: sensitivity 93%, PPV 20%, and accuracy 59%.
Multiparametric MR: sensitivity 93%, PPV 57%, and accuracy of 92% (P < .005). 

This is limited by its retrospective nature, but provides further evidence of the utility of multiparametric MRI in the evaluation of prostate cancer.

PICO Analysis:
Population:

• 133 patients (mean age, 59.3 years) 
• Mean PSA 6.73 ng/mL (median, 4.39 ng/mL) 

Intervention: Multiparametric MR imaging at 3.0 T before radical prostatectomy.
Comparison: Conventional clinical assessment scores (the D'Amico, Epstein, and CAPRA scoring systems)
Outcome: Radical prostatectomy pathology specimen (gross tumour <0.5cc) as Active Surveillance eligible.

Reference: Turkbey et al., Radiology, July 2013, 268(1): 144-152.
Links: Pubmed Full Text